Evidence map›Paper›PMID 41652403›Full record

ArticleWorld journal of surgical oncology2026

Days alive and out of hospital after video-assisted thoracoscopic lobectomy or segmentectomy for lung cancer: a prospective Chinese cohort study.

Wenwu Liu, Yadi Zhang, Cheng Lei, Xin Gao, Yingzhi Zhao, Kaixin Zhang, Kui Gao, Ding Yang, Hongfan Yu, Wei Dai and 3 more

Abstract read
In one paragraph

Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Time toxicity in cancer care: a systematic review of definitions and measurement methods.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wenwu Liu *Department of Anesthesiology, People's Liberation Army the General Hospital of Western Theater Command, Chengdu, China.ORCID http://orcid.org/0000-0002-9377-7761
Yadi Zhang *Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, China.ORCID http://orcid.org/0009-0004-9182-3797
Cheng Lei *Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, China.ORCID http://orcid.org/0000-0003-1311-515X
Xin Gao *Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, China.ORCID http://orcid.org/0000-0002-3089-2279
Yingzhi Zhao *Department of Thoracic Surgery, Public Health Clinical Center of Chengdu, Chengdu, China.ORCID http://orcid.org/0009-0002-2314-8916
Kaixin Zhang *Department of Cardiothoracic Surgery, Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, China.ORCID http://orcid.org/0000-0003-1882-4182
Kui GaoDepartment of Anesthesiology, People's Liberation Army the General Hospital of Western Theater Command, Chengdu, China.
Ding YangDepartment of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID http://orcid.org/0000-0002-6329-8962
Hongfan YuState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.ORCID http://orcid.org/0000-0003-3167-1491
Wei DaiDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, China.ORCID http://orcid.org/0000-0003-1650-1590
Qiang LiDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, China.ORCID http://orcid.org/0000-0003-1841-4132
Qiuling Shi *Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, China. qshi@cqmu.edu.cn.ORCID http://orcid.org/0000-0003-0660-3809
Xing Wei *Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, No. 55, Section 4, South Renmin Road, Chengdu, 610041, China. xing.wei@scszlyy.org.cn.ORCID http://orcid.org/0000-0002-3035-5633

Funding

Ministry of Science and Technology of the People's Republic of China 2022YFE0133100Sichuan Province Key Clinical Specialty Construction N/A
6 · The paper itself

Abstract

objectivesThis study aimed to provide Chinese data on Days Alive and Out of Hospital (DAOH) following video-assisted thoracoscopic surgery (VATS) lobectomy or segmentectomy.

methodsThe analyzed data was derived from a prospective cohort study. Consecutive patients who underwent either VATS lobectomy or segmentectomy from April 2021 to July 2022 were included. The primary outcome was DAOH within the first 90 days postoperatively (DAOH90). The secondary outcomes were identifying the predominant complications and reasons for readmission during the DAOH90. Additionally, we utilized multivariate logistic regression to identify factors independently associated with decreased DAOH90.

resultsA total of 919 primary lung cancer patients were included. The median DAOH90 was 86 days (IQR, 85–87). The predominant postoperative complications within postoperative 90 days (POD90) were pneumonia (22.5%), pleural pneumothorax (15.8%), incision dehiscence (13.8%) and pleural effusion (12.8%). The primary causes of readmission in POD90 included pleural effusion (10 cases), pneumonia (7 cases), and incision dehiscence (4 cases). Age (P < .001), operative time (P < .001), operative bleeding (P = .023) and multiportal VATS (compared with robot-assisted VATS) were independently associated with decreased DAOH90.

conclusionsIn this study, the median DAOH90 following VATS lobectomy or segmentectomy was 86 days. Advanced age, longer surgical duration, more operative bleeding and multiportal VATS may be independent risk factors for “low DAOH90.”

Indexed as

Lung NeoplasmsPatient ReadmissionPneumonectomyPostoperative ComplicationsThoracic Surgery, Video-AssistedAgedChinaEast Asian PeopleFemaleFollow-Up StudiesHumansLength of StayMaleMiddle AgedPrognosisProspective StudiesDays alive and out of hospital (DAOH)Lung cancerPatient-centered outcomesPostoperative complicationsVideo-assisted thoracoscopic surgery (VATS)

Identifiers

PMID41652403
PMCPMC12983843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.